Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Articles By This Author
5 hot insider trades: Dun & Bradstreet, Calavo CEOs buy $1M+ apiece
Investing.com — Here is your Pro Recap of some of the biggest insider trades you might have missed this past week. Dun & Bradstreet chief
Guru Fundamental Report for NNN
Below is Validea’s guru fundamental report for NATIONAL RETAIL PROPERTIES, INC. (NNN). Of the 22 guru strategies we follow, NNN rates highest using our Multi-Factor
Guru Fundamental Report for NEWR
Below is Validea’s guru fundamental report for NEW RELIC INC (NEWR). Of the 22 guru strategies we follow, NEWR rates highest using our P/B Growth
Guru Fundamental Report for SNX
Below is Validea’s guru fundamental report for TD SYNNEX CORP (SNX). Of the 22 guru strategies we follow, SNX rates highest using our Acquirer’s Multiple
Guru Fundamental Report for NVAX
Below is Validea’s guru fundamental report for NOVAVAX INC (NVAX). Of the 22 guru strategies we follow, NVAX rates highest using our Price/Sales Investor model
6 big deal reports: First Republic Bank deal proving ‘elusive’
Investing.com — Here is your Pro Recap of the biggest M&A headlines you may have missed this past week. First Republic Bank deal ‘remains elusive’:
Guru Fundamental Report for SPCE – Benjamin Graham
Below is Validea’s guru fundamental report for VIRGIN GALACTIC HOLDINGS INC (SPCE). Of the 22 guru strategies we follow, SPCE rates highest using our Value
Debt Grows More Expensive, Harder to Get for Startups After SVB Collapse
With Silicon Valley Bank’s future uncertain, startups backed by venture capital looking for new lenders are facing higher borrowing costs, onerous terms or even closed
2 Natural Gas Stocks To Watch Ahead Of April 2023
Natural gas stocks refer to stocks of companies involved in the exploration, production, and distribution of natural gas. Natural gas is a fossil fuel that
Guru Fundamental Report for HCP
Below is Validea’s guru fundamental report for HASHICORP INC (HCP). Of the 22 guru strategies we follow, HCP rates highest using our P/B Growth Investor